St. Jude Medical, Inc. (NYSE:STJ)

St. Jude Medical, Inc., is a medical technology company. The Company is engaged in providing solutions for the treatment of epidemic diseases, including atrial fibrillation, heart failure, stroke, coronary artery disease, congenital heart defects, Parkinson’s disease and chronic pain. The Company’s provides medical solutions for Coronary Artery Disease, Heart Failure, Chronic Pain, Congenital Heart Defects, Heart Valve Disease, and Sudden Cardiac Arrest. Coronary Artery Disease, offers ILUMIEN system imaging platform. Heart Failure, offers Quadripolar Pacing, Thoracic Impedance Monitoring, and Left Atrial Pressure Monitoring. Chronic Pain, offers Spinal cord stimulation devices. Congenital Heart Defects, offers Ventricular Septal Defect Occlusion, Atrial Septal Defect Occlusion, and Patent Ductus Arteriosus Occlusion. Heart Valve Disease, offers Surgical Valve Replacement. Sudden Cardiac Arrest, offers Implantable Cardiac Defibrillation Therapy.

Official website: www.sjm.com